Loading publications…
The last 5 uploaded publications
Impact of lesion preparation and stent optimisation on lesion-oriented events in PCI with drug-eluting stents: 5-year results from the AIDA trial
Mick Renkens, Maik J. Grundeken, Laura S.M. Kerkmeijer, Robin P. Kraak, Deborah N. Kalkman, René J. van der Schaaf, Sjoerd H. Hofma, Karin Arkenbout, Auke Weevers, Karel T. Koch, Yoshinobu Onuma, Patrick W. Serruys, Jan G.P. Tijssen, Robbert J. de Winter, Joanna J. Wykrzykowska, R. Tijssen (2025). Impact of lesion preparation and stent optimisation on lesion-oriented events in PCI with drug-eluting stents: 5-year results from the AIDA trial. Netherlands Heart Journal, DOI: 10.1007/s12471-025-01937-4.
Article146 days agoImplantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial
R. Tijssen, Robin P. Kraak, Joëlle Elias, Ivo M. van Dongen, Deborah N. Kalkman, Martina Nassif, Yohei Sotomi, Taku Asano, Yuki Katagiri, Carlos Collet, Jan J. Piek, José P.S. Henriques, Robbert J. de Winter, Jan G.P. Tijssen, Yoshinobu Onuma, Patrick W. Serruys, Joanna J. Wykrzykowska (2018). Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial. EuroIntervention, 14(4), pp. e434-e442, DOI: 10.4244/eij-d-17-01152.
Article146 days agoThe relationship of pre-procedural Dmax based sizing to lesion level outcomes in Absorb BVS and Xience EES treated patients in the AIDA trial
R. Tijssen, Laura S.M. Kerkmeijer, Yuki Katagiri, Robin P. Kraak, Kuniaki Takahashi, Norihiro Kogame, Ply Chichareon, Rodrigo Modolo, Taku Asano, Martina Nassif, Deborah N. Kalkman, Yohei Sotomi, Carlos Collet, Sjoerd H. Hofma, René J. van der Schaaf, E. Karin Arkenbout, Auke Weevers, Marcel A.M. Beijk, Jan J. Piek, Jan G.P. Tijssen, José P.S. Henriques, Robbert J. de Winter, Yoshinobu Onuma, Patrick W. Serruys, Joanna J. Wykrzykowska (2019). The relationship of pre-procedural Dmax based sizing to lesion level outcomes in Absorb BVS and Xience EES treated patients in the AIDA trial. The International Journal of Cardiovascular Imaging, 35(7), pp. 1189-1198, DOI: 10.1007/s10554-019-01576-y.
Article146 days agoClinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug‐eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease—AIDA trial substudy
R. Tijssen, René J. van der Schaaf, Robin P. Kraak, M Vink, Sjoerd H. Hofma, E. Karin Arkenbout, Auke Weevers, Laura S.M. Kerkmeijer, Yoshinobu Onuma, Patrick W. Serruys, Marcel A.M. Beijk, Karel T. Koch, Jan Baan, Marije M. Vis, Jan J. Piek, Jan G.P. Tijssen, José P.S. Henriques, Robbert J. de Winter, Joanna J. Wykrzykowska (2019). Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug‐eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease—AIDA trial substudy. Catheterization and Cardiovascular Interventions, 95(1), pp. 89-96, DOI: 10.1002/ccd.28193.
Article146 days ago100.84 Long-Term Effects of QCA-Guided Implantation Techniques in Lesion-Oriented Cardiac Events in Patients Undergoing Percutaneous Coronary Intervention Using a 2nd Generation Drug-Eluting Stent.
R. Tijssen, Mick Renkens, Linda G.W. Kerkmeijer, Robin P. Kraak, Maik J. Grundeken, Patrick W. Serruys, Yoshinobu Onuma, Robbert de Winter, Joanna J. Wykrzykowska (2024). 100.84 Long-Term Effects of QCA-Guided Implantation Techniques in Lesion-Oriented Cardiac Events in Patients Undergoing Percutaneous Coronary Intervention Using a 2nd Generation Drug-Eluting Stent.. КАРДИОЛОГИЯ УЗБЕКИСТАНА, 17(4), pp. S27-S27, DOI: 10.1016/j.jcin.2024.01.137.
Article146 days ago